Document Detail

An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
MedLine Citation:
PMID:  12384856     Owner:  NLM     Status:  MEDLINE    
The development of pulmonary aspergilloma and invasive aspergillosis is a rare complication of cystic fibrosis. We describe a 29-year-old patient with cystic fibrosis who had invasive pulmonary aspergillosis that was not cured by amphotericin B, liposomal amphotericin B, or itraconazole. This patient was subsequently successfully treated and cured with the novel antifungal agent voriconazole.
Laura Chow; Neil E Brown; Dennis Kunimoto
Related Documents :
17016306 - Is pulmonary aspiration still an important problem in anesthesia?
22698526 - Feasibility and accuracy of 3dtee versus ct for the evaluation of aortic valve annulus ...
22343496 - Copeptin level and copeptin response to percutaneous balloon mitral valvuloplasty in mi...
24024076 - Onyx embolization of dural arteriovenous fistula, using scepter c balloon catheter: a c...
14567936 - Signal transduction pathways in cerebral vasospasm.
19424856 - Level of cd14+-endothelial progenitor cells is not associated with coronary artery dise...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2002-10-10
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  35     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2002-10-17     Completed Date:  2002-11-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e106-10     Citation Subset:  IM    
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / therapeutic use*
Aspergillosis / drug therapy*,  etiology
Cystic Fibrosis / complications*
Lung Diseases, Fungal / drug therapy*,  etiology
Pyrimidines / therapeutic use*
Treatment Outcome
Triazoles / therapeutic use*
Reg. No./Substance:
0/Antifungal Agents; 0/Pyrimidines; 0/Triazoles; 0/voriconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Colonic necrosis and perforation secondary to Escherichia coli O157:H7 gastroenteritis in an adult p...
Next Document:  Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of popula...